Evidence Library
Filter by drug, type, year, and open access.
Showing 251–300 of 427 results
- Attention deficit hyperactivity disorder: diagnosis and management (NICE guideline NG87) — NICE Guideline NG87 (2018)• Drug: clonidine-erOpen access
- Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: systematic review and network meta-analysis — Lancet Psychiatry (2018)• Drug: clonidine-erDOIPMID
- Attention deficit hyperactivity disorder: diagnosis and management (NICE guideline NG87) — NICE Guideline NG87 (2018)• Drug: guanfacineOpen access
- Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: systematic review and network meta-analysis — Lancet Psychiatry (2018)• Drug: guanfacineDOIPMID
- Attention deficit hyperactivity disorder: diagnosis and management (NICE guideline NG87) — NICE Guideline NG87 (2018)• Drug: viloxazineOpen access
- Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: systematic review and network meta-analysis — Lancet Psychiatry (2018)• Drug: viloxazineDOIPMID
- Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial — The Lancet (2018)• Drug: buprenorphine-naloxoneOpen accessDOIPMIDPMCID
- The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder — American Journal of Psychiatry (2018)• Drug: naltrexoneDOIPMID
- Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial — The Lancet (2018)• Drug: naltrexone-extended-releaseOpen accessDOIPMIDPMCID
- The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder — American Journal of Psychiatry (2018)• Drug: acamprosateDOIPMID
- The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder — American Journal of Psychiatry (2018)• Drug: disulfiramDOIPMID
- Nicotine replacement therapy versus control for smoking cessation — Cochrane Database of Systematic Reviews (2018)• Drug: nicotineOpen accessDOIPMIDPMCID
- AGNP Consensus Guidelines for TDM in Psychiatry — Pharmacopsychiatry (2018)• Drug: amoxapineOpen access
- Benzodiazepines for catatonia: systematic review and meta-analysis — Schizophrenia Research (2018)• Drug: lorazepamDOI
- AGNP Consensus Guidelines for TDM in Psychiatry — Pharmacopsychiatry (2018)• Drug: nefazodoneOpen access
- Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus — CNS Spectrums (2018)• Drug: pimavanserinPMID
- Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder — The Lancet (2018)• Drug: trazodoneDOIPMID
- AGNP Consensus Guidelines for TDM in Psychiatry — Pharmacopsychiatry (2018)• Drug: trimipramineOpen access
- AGNP Consensus Guidelines for TDM in Psychiatry — Pharmacopsychiatry (2018)• Drug: valproate-divalproexOpen access
- Paliperidone palmitate vs oral antipsychotics: comparative effectiveness — Observational (2017)• Drug: paliperidone
- Cariprazine versus risperidone for predominant negative symptoms of schizophrenia — The Lancet (2017)• Drug: cariprazineDOIPMID
- Deutetrabenazine for tardive dyskinesia (AIM-TD phase 3 trial) — The Lancet Psychiatry (2017)• Drug: deutetrabenazineDOI
- KINECT 3: A phase 3 randomized, double-blind, placebo-controlled trial of valbenazine for tardive dyskinesia — American Journal of Psychiatry (2017)• Drug: valbenazineDOI
- Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline — Journal of Clinical Sleep Medicine (2017)• Drug: eszopicloneOpen accessDOIPMIDPMCID
- Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline — Journal of Clinical Sleep Medicine (2017)• Drug: zolpidemOpen accessDOIPMIDPMCID
- Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline — Journal of Clinical Sleep Medicine (2017)• Drug: ramelteonOpen accessDOIPMIDPMCID
- Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline — Journal of Clinical Sleep Medicine (2017)• Drug: suvorexantOpen accessDOIPMIDPMCID
- Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline — Journal of Clinical Sleep Medicine (2017)• Drug: lemborexantOpen accessDOIPMIDPMCID
- Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline — Journal of Clinical Sleep Medicine (2017)• Drug: daridorexantOpen accessDOIPMIDPMCID
- Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline — Journal of Clinical Sleep Medicine (2017)• Drug: zaleplonOpen accessDOIPMIDPMCID
- Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline — Journal of Clinical Sleep Medicine (2017)• Drug: estazolamOpen accessDOIPMIDPMCID
- Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline — Journal of Clinical Sleep Medicine (2017)• Drug: flurazepamOpen accessDOIPMIDPMCID
- Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline — Journal of Clinical Sleep Medicine (2017)• Drug: quazepamOpen accessDOIPMIDPMCID
- Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline — Journal of Clinical Sleep Medicine (2017)• Drug: temazepamOpen accessDOIPMIDPMCID
- Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline — Journal of Clinical Sleep Medicine (2017)• Drug: triazolamOpen accessDOIPMIDPMCID
- Pregabalin for generalized anxiety disorder — International Clinical Psychopharmacology (2017)• Drug: pregabalinDOI
- Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline — Journal of Clinical Sleep Medicine (2017)• Drug: diphenhydramineOpen accessDOIPMIDPMCID
- Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline — Journal of Clinical Sleep Medicine (2017)• Drug: doxylamineOpen accessDOIPMIDPMCID
- Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline — Journal of Clinical Sleep Medicine (2017)• Drug: melatoninOpen accessDOIPMIDPMCID
- Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies — BMJ (2017)• Drug: buprenorphineOpen accessDOIPMIDPMCID
- Buprenorphine for managing opioid withdrawal — Cochrane Database of Systematic Reviews (2017)• Drug: buprenorphineOpen accessDOIPMIDPMCID
- Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies — BMJ (2017)• Drug: buprenorphine-naloxoneOpen accessDOIPMIDPMCID
- Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies — BMJ (2017)• Drug: methadoneOpen accessDOIPMIDPMCID
- A phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal — Drug and Alcohol Dependence (2017)• Drug: lofexidineDOIPMID
- Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis — The Annals of Pharmacotherapy (2017)• Drug: pimavanserinPMID
- Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline — Journal of Clinical Sleep Medicine (2017)• Drug: trazodoneOpen accessDOIPMIDPMCID
- Liraglutide for Prediabetes/Obesity in Clozapine- or Olanzapine-Treated Schizophrenia Spectrum Disorder (RCT) — JAMA Psychiatry (2017)• Drug: semaglutide-ozempicOpen accessPMIDPMCID
- Liraglutide for Prediabetes/Obesity in Clozapine- or Olanzapine-Treated Schizophrenia Spectrum Disorder (RCT) — JAMA Psychiatry (2017)• Drug: semaglutide-wegovyOpen accessPMIDPMCID
- Liraglutide for Prediabetes/Obesity in Clozapine- or Olanzapine-Treated Schizophrenia Spectrum Disorder (RCT) — JAMA Psychiatry (2017)• Drug: tirzepatide-mounjaroOpen accessPMIDPMCID
- Liraglutide for Prediabetes/Obesity in Clozapine- or Olanzapine-Treated Schizophrenia Spectrum Disorder (RCT) — JAMA Psychiatry (2017)• Drug: tirzepatide-zepboundOpen accessPMIDPMCID